Neda Seyedsadjadi

Oct 8, 2024 | onlinelibrary.wiley.com | Neda Seyedsadjadi |Lorenzo Leggio |Mariel Molina-Castro |Danisa Nieto

1 INTRODUCTION There is a growing interest in innovative approaches to treating alcohol use disorder (AUD), including a recent focus on gut-brain peptides that regulate both homeostatic hunger and reward processing and motivation for food-seeking.1-4 One such peptide is glucagon-like peptide-1 (GLP-1), an anorectic incretin hormone derived from intestinal preproglucagon-containing cells and neurons in the nucleus tractus solitarii.5 Indeed, GLP-1 receptor agonists are among the most...

Aug 22, 2023 | mdpi.com | Jessica G. Nicanor-Carreón |Neda Seyedsadjadi |Blair Rowitz |Marta Yanina Pepino

1. IntroductionObesity represents a significant and pressing global health concern, characterized by an excessive accumulation of body fat that poses a substantial risk of developing various chronic diseases, including type 2 diabetes [T2D], cardiovascular disease, and metabolic syndrome, among other medical comorbidities [1]. Epidemiological data from the United States collected between 2017 and 2020 indicate a concerning prevalence rate of 42% for obesity (as reviewed in [2]).